Groep Brussel Lambert NV
OTC:GBLBY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Groep Brussel Lambert NV
OTC:GBLBY
|
BE |
|
QBeyond AG
F:QBY0
|
DE |
|
IAC Inc
NASDAQ:PPLI
|
US |
|
D
|
Dermapharm Holding SE
XBER:DMP
|
DE |
Wall St Price Targets
GBLBY Price Targets Summary
Groep Brussel Lambert NV
According to Wall Street analysts, the average 1-year price target for GBLBY is 10.27 USD with a low forecast of 9.03 USD and a high forecast of 11.16 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GBLBY's stock price target?
Price Target
10.27
USD
According to Wall Street analysts, the average 1-year price target for GBLBY is 10.27 USD with a low forecast of 9.03 USD and a high forecast of 11.16 USD.
What is the Revenue forecast for Groep Brussel Lambert NV?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Groep Brussel Lambert NV?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 9 years is -4%.
What is the Operating Income forecast for Groep Brussel Lambert NV?
Projected CAGR
70%
Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 3 years is 70%.
